Premium
In Vitro Removal of Beta‐2‐Microglobulin From Uremic Blood With an Immunoadsorption Wall
Author(s) -
Yang TsungHua,
Lin BoJhou,
Ma YiLing,
Chou KangJu
Publication year - 2012
Publication title -
artificial organs
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.684
H-Index - 76
eISSN - 1525-1594
pISSN - 0160-564X
DOI - 10.1111/j.1525-1594.2011.01294.x
Subject(s) - immunoadsorption , beta 2 microglobulin , dialysis , amyloidosis , medicine , pathological , uremia , uremic toxins , in vitro , urology , chemistry , hemodialysis , immunology , biochemistry , antibody
Dialysis‐related amyloidosis (DRA), caused by the accumulation of beta‐2‐microglobulin (β‐2M), remains a major concern in long‐term renal replacement therapies. For years, we have developed an immunoadsorption wall (iWall) for the removal of β‐2M. In this study, we employed a new approach taking advantage of the melting of a buffer ice rod to improve the conditions associated with the manufacturing of an iWall and tested its performance with uremic serum and blood. The preliminary results reveal that the present iWalls thus prepared not only possess the superior properties of affinity and specificity but also show structural stability and acceptable hemocompatibility. We believe that this breakthrough might provide a promising path to successful treatment of DRA as well as establish a useful platform for studying removal of certain pathological toxins accumulated in the blood.